Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000017.xml
Exp Clin Endocrinol Diabetes 2023; 131(06): 375-376
DOI: 10.1055/a-2075-0735
DOI: 10.1055/a-2075-0735
Letter to the Editor
The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?

Publication History
Article published online:
09 May 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Asbach E, Kellnar A, Bekeran M. et al. Prevalence of primary aldosteronism in newly diagnosed hypertensive patients in primary care. Exp Clin Endocrinol Diabetes 2022; 130: 801-805
- 2 Funder JW, Carey RM, Mantero F. et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2016; 101: 1889-1916
- 3 Lonati C, Bassani N, Gritti A. et al. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. J Hypertens 2014; 32: 627-634
- 4 Buffolo F, Monticone S, Burrello J. et al. Is primary aldosteronism still largely unrecognized?. Horm Metab Res 2017; 49: 908-914